AHFS Drug Information

AHFS Drug Information


ASHP Health-System Pharmacists


免費Offers In-App Purchases

5.1.1for iPhone, iPad and more
9.9
1 Ratings
Skyscape Medpresso Inc
Developer
11.1 MB
Size
2024年02月26日
Update Date
Medical
Category
Age Rating
4+
Apps in this category do not contain restricted content.
9+
Apps in this category may contain mild or occasional cartoon, fantasy or real-life violence, as well as occasional or mild adult, sexually suggestive or horrifying content and may not be suitable for children under 9 years of age.
12+
Apps in this category may contain occasional mild indecent language, frequent or intense cartoon or real-life violence, minor or occasional adult or sexually suggestive material, and simulated gambling, and may be for children under 12 years of age.
17+
You must be at least 17 years old to access this App.
Apps in this category may contain frequent and intense offensive language; Frequent and intense cartoon, fantasy or realistic violence: frequent and intense adult, scary and sexually suggestive subjects: as well as sexual content, nudity, tobacco, alcohol and drugs, may not be suitable for children under 17 years of age.
AHFS Drug Information 螢幕截圖
AHFS Drug Information 海報AHFS Drug Information 海報AHFS Drug Information 海報AHFS Drug Information 海報AHFS Drug Information 海報AHFS Drug Information 海報AHFS Drug Information 海報AHFS Drug Information 海報
AHFS Drug Information 海報AHFS Drug Information 海報AHFS Drug Information 海報AHFS Drug Information 海報AHFS Drug Information 海報AHFS Drug Information 海報AHFS Drug Information 海報AHFS Drug Information 海報

About AHFS Drug Information

"Try before you buy" - Download the FREE App, which includes sample content. An in-App purchase is required to unlock all content.

AHFS Drug Information® 2024: AHFS® Drug Information™ - Doody's Core Title - is your comprehensive, interactive treatment and drug therapy solution - complete with therapeutic guidelines and off-label uses.

Named a Doody's Core Title in 2023!
AHFS Drug Information® 2024 contains the most dependable drug information available?all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.
With expanded and revised content supported by more than 97,000 references and incorporating the advice of numerous subject matter experts, AHFS DI helps you protect your patients and your practice.
Updates in the new edition:
* Clinical perspective sections that include place of therapy discussions and recommendations from therapeutic guidelines
* Expanded coverage of specialty medications used to treat a variety of complex, chronic conditions that often require special handling and administration and may require careful oversight to manage severe adverse effects and dosage adjustments
* Contemporary topics such as new RSV treatments and vaccines, safety issues associated with the glucagon-like peptide 1 (GLP-1) agonists, novel orphan drugs, biosimilars, and more
* Expanded content on new and emerging gene therapies
* Updates to a variety of vaccine monographs including the pneumococcal, rabies, and respiratory syncytial virus vaccines Expanded content on off-label uses and long-term clinical data
* MedWatch alerts, Standardize4Safety information, REMS data, and focused FDA updates for various medications
* New content on over 175 new molecular entities (NMEs) or new therapeutic biological products and substantive revisions on approximately 190 medications
* Searchable and scalable database where you can search the index or perform a full-text search
* Ability to create user-specific favorites and add notes
* AHFS class for each drug based on the AHFS® Pharmacologic-Therapeutic Classification

No internet connection is required to access the content after the initial download. Find information quickly using powerful SmartSearch technology. Search part of term for those hard to spell medical terms.

Content licensed from printed ISBN 10: 1585287210
Content licensed from printed ISBN 13: 9781585287215

SUBSCRIPTION :
Please purchase a yearly auto-renewing subscription to receive content access and available updates.

Yearly auto-renewing payments- $99.99

Payment will be charged to your iTunes Account at confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Subscription may be managed by the user and auto-renewal can be disabled at any time by going to your device “Settings” and tapping “iTunes & App Store”. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable.

If you have any questions or comments, email us any time: customersupport@skyscape.com or call 508-299-3000

Privacy Policy - https://www.skyscape.com/terms-of-service/privacypolicy.aspx
Terms and Conditions - https://www.skyscape.com/terms-of-service/licenseagreement.aspx

Author(s): Gerald K. McEvoy, Pharm.D, Editor-in-Chief: Elaine K. Snow
Publisher: American Society of Health-System Pharmacists
Show More

最新版本5.1.1更新日誌

Last updated on 2024年02月26日
歷史版本
We want you to get notified about exclusive offers, promotions, and discounts. This updates does this directly through in-app notifications.

Experience the full power of having AHFS Drug Information® 2024 for healthcare professionals including pharmacist a mobile app,

The latest version includes:

- Clinical perspective sections that include place of therapy discussions and recommendations from therapeutic guidelines
- Expanded coverage of specialty medications used to treat a variety of complex, chronic conditions that often require special handling and administration and may require careful oversight to manage severe adverse effects and dosage adjustments
- Contemporary topics such as new RSV treatments and vaccines, safety issues associated with the glucagon-like peptide 1 (GLP-1) agonists, novel orphan drugs, biosimilars, and more
- Expanded content on new and emerging gene therapies
- Updates to a variety of vaccine monographs including the pneumococcal, rabies, and respiratory syncytial virus vaccines
- Expanded content on off-label uses and long-term clinical data
- MedWatch alerts, Standardize4Safety information, REMS data, and focused FDA updates for various medications
- New content on over 175 new molecular entities (NMEs) or new therapeutic biological products and substantive revisions on approximately 190 medications

Also check out these feature releases in the mobile app:

- Read alerts under MedBeats relevant to your specialty
- Use "Spotlight Search" from Home screen
- Audio notes: to quickly record notes on the go
- Text notes: to record notes if you prefer
- Zoom in or out on images with pinch action
- Robust Indices for quick navigation like Image index & Table Index
- Smart search: search content for a term or topic to find information quickly
- History tracks your searches so you can revisit the topic when charting or care planning
- Bookmark topics that you frequently access
Show More
Version History
5.1.1
2024年02月26日
We want you to get notified about exclusive offers, promotions, and discounts. This updates does this directly through in-app notifications.

Experience the full power of having AHFS Drug Information® 2024 for healthcare professionals including pharmacist a mobile app,

The latest version includes:

- Clinical perspective sections that include place of therapy discussions and recommendations from therapeutic guidelines
- Expanded coverage of specialty medications used to treat a variety of complex, chronic conditions that often require special handling and administration and may require careful oversight to manage severe adverse effects and dosage adjustments
- Contemporary topics such as new RSV treatments and vaccines, safety issues associated with the glucagon-like peptide 1 (GLP-1) agonists, novel orphan drugs, biosimilars, and more
- Expanded content on new and emerging gene therapies
- Updates to a variety of vaccine monographs including the pneumococcal, rabies, and respiratory syncytial virus vaccines
- Expanded content on off-label uses and long-term clinical data
- MedWatch alerts, Standardize4Safety information, REMS data, and focused FDA updates for various medications
- New content on over 175 new molecular entities (NMEs) or new therapeutic biological products and substantive revisions on approximately 190 medications

Also check out these feature releases in the mobile app:

- Read alerts under MedBeats relevant to your specialty
- Use "Spotlight Search" from Home screen
- Audio notes: to quickly record notes on the go
- Text notes: to record notes if you prefer
- Zoom in or out on images with pinch action
- Robust Indices for quick navigation like Image index & Table Index
- Smart search: search content for a term or topic to find information quickly
- History tracks your searches so you can revisit the topic when charting or care planning
- Bookmark topics that you frequently access
5.0.10
2023年07月12日
- New Edition
5.0.7
2022年04月23日
- UIUX enhancements
- Management of opiate use disorder
- Multimodal pain management strategies for non-opiate analgesic agents and opiate-sparing drugs
- Current best practices for management of pain and sedation in critically ill patients such as the concept of analgosedation and comparisons of various sedative agents used for ICU sedation
- Newly published information on breakthrough oncology drugs approved as part of the FDA’s accelerated approval program
4.4.1
2020年07月23日
Fixes related to connecting to iTunes for in-app purchases in iOS version 13.4 and above
3.2.7
2018年06月18日
- iPhone X support
- UI/UX enhancement
- Minor bug fixes
3.2.5
2018年04月03日
- iPhone X support
- UI/UX enhancement
- 3D Touch
- Minor bug fixes
1.8.181
2017年09月17日
UI/UX Enhancements
1.7.150
2017年04月05日
- UI enhancements
1.7.9
2016年12月19日
Minor bug fixes related to iOS 10
1.7.8
2016年07月07日

AHFS Drug Information FAQ

點擊此處瞭解如何在受限國家或地區下載AHFS Drug Information。
以下為AHFS Drug Information的最低配置要求。
iPhone
須使用 iOS 12 或以上版本。
iPad
須使用 iPadOS 12 或以上版本。
Mac
須使用 macOS 10.15 或以上版本。
iPod touch
須使用 iOS 12 或以上版本。
AHFS Drug Information支持英文
AHFS Drug Information包含應用內購買。 以下為AHFS Drug Information應用內購買價格清單。
AHFS Drug Info 1/Y sub offer
HK$ 628.00
AHFS Drug Information 1/Y sub
HK$ 778.00

AHFS Drug Information相關應用

你可能還喜歡

Skyscape Medpresso Inc 開發者的更多應用